FSTLX
Price
$34.55
Change
+$0.14 (+0.41%)
Updated
Oct 17 closing price
Net Assets
1.94B
RMFCX
Price
$61.51
Change
+$0.17 (+0.28%)
Updated
Oct 17 closing price
Net Assets
110.88B
Interact to see
Advertisement

FSTLX vs RMFCX

Header iconFSTLX vs RMFCX Comparison
Open Charts FSTLX vs RMFCXBanner chart's image
Federated Hermes MDT Large Cap Value R6
Price$34.55
Change+$0.14 (+0.41%)
VolumeN/A
Net Assets1.94B
American Funds American Mutual R3
Price$61.51
Change+$0.17 (+0.28%)
VolumeN/A
Net Assets110.88B
FSTLX vs RMFCX Comparison Chart in %
View a ticker or compare two or three
VS
FSTLX vs. RMFCX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSTLX is a StrongBuy and RMFCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 111B vs. FSTLX (1.94B). RMFCX pays higher dividends than FSTLX: RMFCX (1.20) vs FSTLX (1.06). FSTLX was incepted earlier than RMFCX: FSTLX (9 years) vs RMFCX (23 years). RMFCX (0.91) is less costly to investors than FSTLX (0.85). FSTLX is a more actively managed with annual turnover of: 69.00 vs. RMFCX (31.00). FSTLX has a lower initial minimum investment than RMFCX: FSTLX (0) vs RMFCX (250). RMFCX annual gain was more profitable for investors over the last year : 4.67 vs. FSTLX (-2.83). RMFCX return over 5 years is better than : 56.66 vs. FSTLX (39.29).
FSTLXRMFCXFSTLX / RMFCX
Total Expense Ratio0.700.9177%
Annual Report Gross Expense Ratio0.850.9193%
Fund Existence9 years23 years-
Gain YTD12.45713.37593%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.94B111B2%
Annual Yield % from dividends1.061.2088%
Returns for 1 year-2.834.67-61%
Returns for 3 years30.0538.4178%
Returns for 5 years39.2956.6669%
Returns for 10 yearsN/A90.65-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLYYF0.41N/A
N/A
Celyad Oncology SA
FGROF2.75N/A
N/A
Firstgroup PLC
JFEEF12.04N/A
N/A
JFE Holdings Inc.
CIXPF9.91-0.18
-1.78%
Caixabank SA
QUEXF0.65-0.06
-8.45%
Q2 METALS CORP